Pleasanton, California, October 13, 2026 / PRNewswire / -- 10x Genomics, Inc. (Nasdaq ticker: TXG) announces that it will release its financial results for the third quarter ending September 30, 2026, after the close of U.S. markets on Thursday, November 5, 2026.
The company will hold a conference call and webcast for analysts and investors at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss financial results, business progress, and outlook. A press release regarding the financial report will be available on the company's website before the conference call.
The audio from the live webcast can be listened to on the company's website in the " Investors " section: https :// investors.10xgenomics.com. This live webcast will be archived and replay available for at least 45 days after the event has concluded.
About 10x Genomics
10x Genomics is a life science and technology company dedicated to developing products that accelerate biological research and promote progress in human health. The company's comprehensive research solutions include instruments, consumables, and software for single-cell and spatial biology, which help academic and translational researchers, as well as biopharmaceutical companies, to understand biological systems with resolution and scale that match the complexity of life. The company's products have contributed to breakthroughs in fields such as oncology, immunology, and neuroscience, driving important discoveries that have changed the world's understanding of health and disease. For more information, visit 10xgenomics.com, or follow the company on LinkedIn, X, Facebook, Bluesky, or YouTube.
Disclosure of Information
10x Genomics indicates that the company uses documents submitted to the U.S. Securities and Exchange Commission, its corporate website ( https :// www.10xgenomics.com /), press releases, public webcasts, and social media accounts as means to disclose significant non-public information and to fulfill its Regulation FD disclosure obligations.
Contact Information
Investors: [ email protected ]
Media: [ email protected ]
